Mehdi Brahmi

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

Desmoplastic small round cell tumor.

Desmoplastic small round cell tumor.

Journal: Current opinion in oncology

Published: April 29, 2026

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort.

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2026

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases.

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases.

Journal: Histopathology

Published: February 24, 2026

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

Journal: Cancer research communications

Published: January 30, 2026

Deni Study: Real-World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group.

Deni Study: Real-World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group.

Journal: International journal of cancer

Published: January 26, 2026

Sarcoma: 10 key messages

Sarcoma: 10 key messages

Journal: La Revue du praticien

Published: January 23, 2026

An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.

An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.

Journal: Expert review of anticancer therapy

Published: December 31, 2025

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Journal: Cancer

Published: December 24, 2025

Mutation type, tyrosine kinase function in normal cell and tyrosine kinase inhibitor activity in cancers.

Mutation type, tyrosine kinase function in normal cell and tyrosine kinase inhibitor activity in cancers.

Journal: Scientific reports

Published: November 05, 2025

Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group.

Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 12, 2025

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 10, 2025

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 10, 2025

Showing 1-12 of 121

Last Updated: 09/26/2026